← Back

Natural Alternatives International

1.43-48.2%1Y · USD

Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements in the United States and internationally. It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company provides private-label contract manufacturing for vitamins, minerals, herbal and other nutritional supplements, as well as strategic partnering services such as customized product formulation, clinical study design, regulatory compliance, and packaging design. It also sells beta-alanine under the CarnoSyn, TriBsyn, and SR CarnoSyn names. Founded in 1980, it is headquartered in Carlsbad, California.

Price · split & dividend adjusted
News & notes moving NAII
United States
NAII▼

Natural Alternatives Posts Q4 GAAP Loss of $2.23 Per Share on $34.5M Revenue

Natural Alternatives International reported a fourth-quarter GAAP loss of $2.23 per share on revenue of $34.5 million, up 1.9% year over year. For the fiscal year ended June 30, 2026, net sales rose $12.7 million, or 10%, to $142.5 million from $129.9 million a year earlier. The company's full-year net loss widened to $20.7 million, or $3.43 per diluted share, compared with a net loss of $13.6 million, or $2.28 per diluted share, in fiscal 2025. As of June 30, 2026, Natural Alternatives held cash of $7.5 million and working capital of $27.7 million, down from $12.3 million and $30.5 million respectively a year earlier. The shares fell 2.86%.
NAII · Capital · Negative Q4 GAAP loss of $2.23/share and widened full-year net loss of $20.7M, with cash and working capital both declining year over year.
Read original ↗
Seeking Alpha·7dRead more →